FDA accelerates complex generic drug approval process

Kathryn Haake

05 October 2017

FDA accelerates complex generic drug approval process

Pharmaceutical companies are strongly against the changes., Images Money

Food and Drug Administration Commissioner Scott Gottlieb on Monday said the FDA is introducing new policies to streamline the approval process for complex generic drugs, making it easier to bring generic competition to the complex brand-name drug market.